Adding to the good news of enrolling our first patient, the FDA has just designated SkinTE a Regenerative Medicine Advanced Therapy. #RMATs are novel regenerative therapies that address unmet needs, which SkinTE demonstrated in our prior clinical data. https://t.co/3JDiDzQes9
We are excited to announce the enrollment of our first patient in our Phase III Pivotal Study evaluating Investigational New Drug SkinTE for the treatment of diabetic foot ulcers. We are incredibly thankful for the patients and investigators. https://t.co/X26viu80cA
Shelby Powers from Dr. Hannan’s lab shows loss of regenerative capacity of pelvic ganglia neurons following radiation. #AUA18@Hannan_Lab@SAPowers123 @jsexmed
Dr. Liu shows preliminary preclinical results showing loss of function with penile Botox injections raising important questions. #AUA18@brady_urology @jsexmed
@scojo_mojo @MaxKates@brady_urology@tbivala1@DrGreg_MD Promising that the conduits didn’t fail immediately, lasted avg 200 days with urothelial and smooth muscle recapitulation suggesting feasibility but the need to optimize. Wrights’ First flight was only 120ft!
Dr. Bivalacqua presents final results of Phase I neourinary conduit trial. Very promising results but still needs optimization. #aua18@brady_urology@tbivala1@DrGreg_MD